Best in Biotech 28 Feb 2025 Rare Disease Day: seven drugs awaiting approval in 2025 …of factor 9 in hemophilia B. It is designed to lower antithrombin, a protein in the blood that prevents blood clots from forming, in order to avoid bleeds. In two… February 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored 13 Nov 2017 Top 5 Things to Know About Immunotherapies – A Review Immunotherapy – A big word with much meaning. There’s no use in talking about their history. The fact that immunotherapies seem to be the next big thing in biotech is… November 13, 2017 - 13 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2022 Redx presents data confirming anti-fibrotic effects of lung disease drug …in a day), and no serious adverse events were observed in the multiple dose phase (dosed at 50mg twice daily for 14 days), with only transient, reversible, mild adverse events… October 3, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2018 This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39% The wireless system for diabetes management developed by Cellnovo can significantly reduce life-threatening events of hypoglycemia in patients with type 1 diabetes. A clinical study that followed type 1 diabetes… February 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jun 2023 Trial shows colorectal cancer drug efficacy …safety profile of fruquintinib in FRESCO-2 was consistent with previously reported fruquintinib studies. Grade 3 or higher adverse events occurred in 63% of patients who received fruquintinib plus BSC, compared… June 19, 2023 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2017 Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns …events (e.g., secondary leukemias). However, most study subjects have not been followed for very long, thus limiting the ability to assess the risk of delayed events. The potential for genotoxicity… July 11, 2017 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jul 2023 FDA approves Beyfortus ahead of 2023-24 RSV season …overall rates of adverse events were comparable between Beyfortus and placebo and the majority of adverse events were mild or moderate in severity. The most common adverse events were rash… July 18, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Late-breaking data shows significant remission in children with EoE …presented which found higher dose Dupixent led to a 3.09 percentile increase in body weight for age percentile from baseline, compared to 0.29 for placebo. Adverse events Safety results were… October 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2024 Six exosome therapy companies driving development in the field …the latest biotech news! By clicking this I agree to receive Labiotech’s newsletter and understand that my personal data will be processed according to the Privacy Policy.* Company name* Job… November 12, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway …GPCR therapeutic targets are yet to be drugged, representing untapped opportunities for drug discovery and development to address numerous diseases. In this article, we take a look at eight biotechs… October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jul 2022 SOTIO Biotech starts solid tumor trial SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group is starting its phase 2 trial on patients with selected advanced/refractory solid tumors. The company has dosed its first… July 27, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 18 Jan 2023 Innovation in life sciences requires collaboration and community …proximity, coffee breaks and social events. It is natural to work next to an expert from another organisation, striking impromptu meetings and discussions which can lead almost anywhere. Open workspaces… January 18, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email